These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8415817)

  • 41. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A; Monferini E; Borsini F
    Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
    Grasso C; Li Volsi G; Barresi M
    Arch Ital Biol; 2016 Jun; 154(2-3):39-49. PubMed ID: 27918061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord.
    Marlier L; Teilhac JR; Cerruti C; Privat A
    Brain Res; 1991 May; 550(1):15-23. PubMed ID: 1832328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites.
    Sprouse JS; McCarty DR; Dudley MW
    Brain Res; 1993 Jul; 617(1):159-62. PubMed ID: 8374738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
    Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
    J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain.
    Fabre V; Boni C; Mocaër E; Lesourd M; Hamon M; Laporte AM
    Eur J Pharmacol; 1997 Oct; 337(2-3):297-308. PubMed ID: 9430429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR; Pluchino RS
    Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
    Shenker A; Maayani S; Weinstein H; Green JP
    Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets.
    Ieni JR; Meyerson LR
    Life Sci; 1988; 42(3):311-20. PubMed ID: 2961966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.